Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | TERT | O14746 | 6/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19962917 | 0.79 | CA1 (0.46) | ALDH1A1KMT2ATERTMEN1KDM4E | |
| SCHEMBL10056890 | 0.79 | KDM4E (0.64) | ALDH1A1KMT2ATERTMEN1KDM4E | |
| SCHEMBL7923976 | 0.79 | KDM4E (0.53) | ALDH1A1KMT2ATERTMEN1KDM4E | |
| SCHEMBL23130687 | 0.78 | ALDH1A1 (0.65) | ALDH1A1KMT2ATERTKDM4E | |
| SCHEMBL11513168 | 0.78 | KDM4E (0.51) | ALDH1A1KMT2ATERTMEN1KDM4E | |
| SCHEMBL10035653 | 0.76 | TERT (0.54) | TERT | |
| SCHEMBL18843662 | 0.76 | ALDH1A1 (0.68) | ALDH1A1KMT2AMEN1 | |
| SCHEMBL18843660 | 0.76 | ALDH1A1 (0.68) | ALDH1A1KMT2AMEN1 | |
| SCHEMBL14367687 | 0.75 | TERT (0.48) | ALDH1A1TERTKDM4E | |
| SCHEMBL14399200 | 0.75 | HPGD (0.63) | ALDH1A1KMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8110404-B2 | Luminescent lanthanide binding chelates | BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2012-02-07 | — | — | US | disclosed |
| US-8110404-B2 | Luminescent lanthanide binding chelates | BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2012-02-07 | — | — | US | disclosed |
| US-20080299675-A1 | Luminescent Lanthanide Binding Chelates | BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2008-12-04 | — | — | US | disclosed |
| US-20080299675-A1 | Luminescent Lanthanide Binding Chelates | BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2008-12-04 | — | — | US | disclosed |
| WO-2007055700-A1 | LUMINESCENT LANTHANIDE BINDING CHELATES | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2007-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080299675-A1 | Luminescent Lanthanide Binding Chelates | HLCS, LYAR, SLC6A13 | ALDH1A1 2754/4885KMT2A 2256/4885NPSR1 1879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.